Sfoglia per Autore
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?
2022 Magnoni, F; Corso, G; Gilardi, L; Pagan, E; Massari, G; Girardi, A; Ghidinelli, F; Bagnardi, V; Galimberti, V; Grana, C; Veronesi, P
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center
2022 Nicosia, L; Lissidini, G; Sargenti, M; Bozzini, A; Farante, G; Vila, J; Oriecuia, C; Pagan, E; Bagnardi, V; Lazzeroni, M; Pesapane, F; Sangalli, C; Galimberti, V; Cassano, E; Veronesi, P
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)
2022 Mazzanti, A; Trancuccio, A; Kukavica, D; Pagan, E; Wang, M; Mohsin, M; Peterson, D; Bagnardi, V; Zareba, W; Priori, S
Different Response to Immunotherapy According to Melanoma Histologic Subtype
2022 Pala, L; Conforti, F; Pagan, E; Bagnardi, V; De Pas, T; Mazzarol, G; Barberis, M; Pennacchioli, E; Orsolini, G; Prestianni, P; Zagami, P; Nicolo', E; Patane, D; Saponara, M; Queirolo, P
Sex-based differences in cancer immunotherapy efficacy
2021 Pagan, E
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas
2021 Ramadan, S; Ceparano, G; Cignetti, A; Sammassimo, S; Bagnardi, V; Pagan, E; Gottardi, D; Fiori, S; Passerini, R; Radice, T; Saglio, G; Tarella, C
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials
2021 Conforti, F; Pala, L; Pagan, E; Corti, C; Bagnardi, V; Queirolo, P; Catania, C; De Pas, T; Giaccone, G
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment
2021 Corso, G; Kahler-Ribeiro-Fontana, S; Pagan, E; Bagnardi, V; Magnoni, F; Munzone, E; Bottiglieri, L; Veronesi, P; Galimberti, V
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up
2021 Kahler-Ribeiro-Fontana, S; Pagan, E; Magnoni, F; Vicini, E; Morigi, C; Corso, G; Intra, M; Canegallo, F; Ratini, S; Leonardi, M; La Rocca, E; Bagnardi, V; Montagna, E; Colleoni, M; Viale, G; Bottiglieri, L; Grana, C; Biasuz, J; Veronesi, P; Galimberti, V
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
2021 Conforti, F; Pala, L; Pagan, E; Bagnardi, V; De Pas, T; Queirolo, P; Pennacchioli, E; Catania, C; Cocorocchio, E; Ferrucci, P; Saponara, M; Orsolini, G; Zagami, P; Nicolo, E; De Marinis, F; Tortora, G; Bria, E; Minucci, S; Joffe, H; Veronesi, P; Wargo, J; Rosenthal, R; Swanton, C; Mantovani, A; Gelber, R; Viale, G; Goldhirsch, A; Giaccone, G
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis
2021 Bianco, N; Palazzo, A; Pagan, E; Bagnardi, V; Milano, M; De Maio, A; Colleoni, M
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis
2021 Conforti, F; Pala, L; Sala, I; Oriecuia, C; De Pas, T; Specchia, C; Graffeo, R; Pagan, E; Queirolo, P; Pennacchioli, E; Colleoni, M; Viale, G; Bagnardi, V; Gelber, R
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials
2021 Munzone, E; Pagan, E; Bagnardi, V; Montagna, E; Cancello, G; Dellapasqua, S; Iorfida, M; Mazza, M; Colleoni, M
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial
2021 Dellapasqua, S; Aliaga, P; Munzone, E; Bagnardi, V; Pagan, E; Montagna, E; Cancello, G; Ghisini, R; Sangalli, C; Negri, M; Mazza, M; Iorfida, M; Cardillo, A; Sciandivasci, A; Bianco, N; De Maio, A; Milano, M; Campenni, G; Sansonno, L; Viale, G; Morra, A; Leonardi, M; Galimberti, V; Veronesi, P; Colleoni, M
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation
2021 Masperi, A; Cubadda, V; Bombelli, L; Labruna, R; Bagnardi, V; Fodor, C; Pagan, E; Bonomo, G; Orsi, F
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
2021 Conforti, F; Pala, L; Pagan, E; Rocco, E; Bagnardi, V; Montagna, E; Peruzzotti, G; De Pas, T; Fumagalli, C; Pileggi, S; Pesenti, C; Marchini, S; Corso, G; Marchio’, C; Sapino, A; Graffeo, R; Collet, L; Aftimos, P; Sotiriou, C; Piccart, M; Gelber, R; Viale, G; Colleoni, M; Goldhirsch, A
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
2020 Montagna, E; Cancello, G; Pagan, E; Bagnardi, V; Munzone, E; Dellapasqua, S; Viale, G; Mazzarol, G; Veronesi, P; Galimberti, V; Santomauro, G; Colleoni, M
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
2020 Corso, G; Gilardi, L; Girardi, A; De Scalzi, A; Pagani, G; Rossi, E; Montagna, G; Veronesi, P; Pagan, E; Bagnardi, V; Grana, C
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast
2020 Lazzeroni, M; Decensi, A; Guerrieri-Gonzaga, A; Pagan, E; Bagnardi, V; Macis, D; Serrano, D; Vingiani, A; Bonizzi, G; Barberis, M; Pruneri, G; Wagner, S; Gandini, S; Viale, G; Bonanni, B
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study
2020 Rizzo, S; De Piano, F; Buscarino, V; Pagan, E; Bagnardi, V; Zanagnolo, V; Colombo, N; Maggioni, A; Del Grande, M; Del Grande, F; Bellomi, M; Aletti, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile